BioScrip, Inc. (BIOS) Misses Q2 EPS by 6c
Get Alerts BIOS Hot Sheet
Join SI Premium – FREE
BioScrip, Inc. (NASDAQ: BIOS) reported Q2 EPS of ($0.07), $0.06 worse than the analyst estimate of ($0.01). Revenue for the quarter came in at $155.9 million versus the consensus estimate of $153.76 million.
For earnings history and earnings-related data on BioScrip, Inc. (BIOS) click here.
For earnings history and earnings-related data on BioScrip, Inc. (BIOS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- SmartFinancial (SMBK) Tops Q1 EPS by 8c
- Scorpius Holdings (SCPX) Receives Nasdaq Filing Delinquency Notification
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!